NIH-funded research R01 grant

Nerve peptide that may worsen Staph bone infections

Official title: Substance P exacerbation of staphylococcal bone damage

Funded at University of North Carolina Charlotte · NIH-11137131 · Data updated 2026-11-12

This work is finding out whether a nerve chemical called substance P makes Staphylococcus aureus bone infections more inflammatory and damaging for people with osteomyelitis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of North Carolina Charlotte
NIH-funded
Lab location1 site (Charlotte, United States)
Project startSeptember 19, 2022
Project endJuly 31, 2027
Funding year2025
Award (this year)$382,454
NIH project number5R01AI170012-04
Project IDNIH-11137131 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people with Staphylococcus aureus bone infections (osteomyelitis) who might donate bone or tissue samples now or be eligible for future trials targeting substance P pathways.

Less likely to help

People whose bone problems are due to non-infectious causes or other types of bacteria not driven by the same inflammatory pathways may not receive direct benefit from this work.

What this research studies

You should know that researchers will use both mouse infection models and isolated human bone cells in the lab to see how substance P affects bone inflammation, osteoclast and osteoblast behavior, and bacterial-driven bone loss. They will expose bone cells to Staphylococcus aureus and substance P to track immune signals and cell responses, and test whether blocking the substance P receptor (NK-1R) reduces damage. The project combines cell-culture experiments using human and murine cells with established in vivo animal models to observe bone destruction over time. The aim is to generate findings that could guide therapies to protect bone during staph infections.

Why it matters

Potential benefit: If successful, this could point to treatments that block substance P signaling to reduce inflammation and bone loss in staphylococcal osteomyelitis.

How similar studies have gone: Previous preclinical studies show substance P can worsen inflammation in other tissues and can change bone-cell responses, but applying NK-1R blockade to staphylococcal osteomyelitis is relatively novel.

Where this research is happening

  • University of North Carolina Charlotte
    Charlotte, United States
    Active

Researchers

  • Principal investigator: Marriott, Ian — University of North Carolina Charlotte
  • Study coordinator: Marriott, Ian

Related research

Other NIH-funded projects on the same topics.

  • Understanding how fetal male germ cells fix DNA breaks

    Researchers are studying how DNA damage in fetal male germ cells is repaired to keep future sperm healthy.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11627830

  • Automated single-cell heart cell measurements to test drugs

    A new automated system will quickly measure electrical signals and beating force in heart cells derived from a patient’s own stem cells to help predict drug safety.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11464806

  • Innate Immune Trigger to Boost Bone Infection Defense

    Researchers are testing a way to wake up the body's own innate immune system to fight stubborn bone infections caused by Staphylococcus aureus, aiming to help people with osteomyelitis fight bacteria more effectively.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11441932

  • Targeting Perp in pancreatic cancer and its muscle wasting

    This NIH grant explores a gene called Perp as a potential target to slow pancreatic cancer growth and reduce cachexia in patients.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11394547

  • Substance P and worsening bone infection from staph bacteria

    Aims to understand if a nerve-related molecule called substance P makes bone infection from Staphylococcus aureus worse.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11384609

  • Deciphering Pemphigus Risk Through Immune Gene Maps

    A study to map the genetic and immune signals that raise the risk of pemphigus, a rare autoimmune skin disease, in adults.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11382943

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.